Medicaid advocates say critics use loaded terms to gain edge in Congressional debate

Bavar­i­an Nordic’s mpox vac­cine Jyn­neos gen­er­at­ed a sim­i­lar im­mune re­sponse in ado­les­cents as it did in adults, of­fer­ing en­cour­ag­ing re­sults that sug­gest the shot would

Sanofi is part­ing ways with the nat­ur­al killer cell com­pa­ny Kiadis, three and a half years af­ter buy­ing it for $357 mil­lion. The move was